FIELD: medicine, cellular neurotransplantation. SUBSTANCE: method of preparing involves abortive embryo (age is 8-10 weeks of gestation) brain tissue suspending, separation of brain cells from lymphoid and erythroid cells by incubation and freezing in medium containing rabbit antibodies raised to glyofibrillar and GaIC-antigen followed by defrosting and separation of neurons from glyal cells by adsorption of the latter on immobilized antibodies to Fc-fragment of rabbit IgG. Preparation is used for cytotransfusion in therapy of some nervous-psychic disorders. EFFECT: improved method of preparing. 3 cl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| BIOENGINEERING METHOD FOR BRAIN FUNCTIONS REPAIR | 1998 |
|
RU2152038C1 |
| BIOENGINEERING METHOD FOR REMODELING CEREBRAL VASCULAR SYSTEM | 1998 |
|
RU2152039C1 |
| ANTITUMORAL AGENT ON BASIS OF IMMUNOPOLISOME BIOLOGICAL STRUCTURE, WAY OF ITS OBTAINING AND VECTORIAL DELIVERY IN CENTRAL NERVOUS SYSTEM AT TUMORAL PROCESS | 2007 |
|
RU2336901C1 |
| MULTI-PURPOSE HETEROGENEOUS COLLAGEN MATRIX APPLIED FOR IMPLANTATION AND METHOD FOR ITS OBTAINING | 2003 |
|
RU2249462C1 |
| METHOD FOR OBTAINING LINING CELLS FROM THE OLFACTORY LINING OF MAMMALS FOR THE TREATMENT OF SPINAL CORD INJURIES | 2017 |
|
RU2676142C2 |
| METHOD FOR ISOLATING THE ENDOTHELIUM OF RAT BRAIN MICROVESSELS | 2021 |
|
RU2774603C1 |
| PRODUCTION OF TERMINAL-DIFFERENTIATED DOFAMINNERGIC NEURONES FROM EMBRIONIC HUMAN FOUNDER CELLS | 2004 |
|
RU2345133C2 |
| NOOTROPIC COMPOSITION BASED ON POLYPEPTIDE COMPLEXES ISOLATED FROM GLIAL PROGENITOR CELLS UNDER CONDITIONS OF HEAT SHOCK, AND A METHOD FOR PRODUCTION THEREOF | 2019 |
|
RU2732599C1 |
| PRODUCTION OF GABA-ergic NEURONS in vitro OF EMBRYO STEM CELLS AND APPLICATION THEREOF IN TREATING NEURAL DISORDERS | 2004 |
|
RU2380410C2 |
| GENETIC CONSTRUCT CONTAINING hGDNF CONTROLLED BY TEMPERATURE-SENSITIVE PROMOTOR FOR REGULATED NEUROTROPHIC FACTOR EXPRESSION IN MAMMALIAN CELLS AND BODIES DIRECTLY | 2012 |
|
RU2527169C2 |
